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Abstract
Bone marrow (BM)-derived endothelial progenitor cells (EPC) have therapeutic potentials in promoting tissue regeneration,
but how these cells are modulated in vivo has been elusive. Here, we report that RBP-J, the critical transcription factor
mediating Notch signaling, modulates EPC through CXCR4. In a mouse partial hepatectomy (PHx) model, RBP-J deficient
EPC showed attenuated capacities of homing and facilitating liver regeneration. In resting mice, the conditional deletion of
RBP-J led to a decrease of BM EPC, with a concomitant increase of EPC in the peripheral blood. This was accompanied by a
down-regulation of CXCR4 on EPC in BM, although CXCR4 expression on EPC in the circulation was up-regulated in the
absence of RBP-J. PHx in RBP-J deficient mice induced stronger EPC mobilization. In vitro, RBP-J deficient EPC showed
lowered capacities of adhering, migrating, and forming vessel-like structures in three-dimensional cultures. Over-expression
of CXCR4 could at least rescue the defects in vessel formation by the RBP-J deficient EPC. These data suggested that the
RBP-J-mediated Notch signaling regulated EPC mobilization and function, at least partially through dynamic modulation of
CXCR4 expression. Our findings not only provide new insights into the regulation of EPC, but also have implications for
clinical therapies using EPC in diseases.
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Introduction
Recently, bone marrow (BM)-derived cells, such as the
hematopoietic stem cells (HSC), the mesenchymal stem cells
(MSC), and the endothelial progenitor cells (EPC), have shown
promising potential in the treatment of various human disease
[1,2]. For example, several reports have documented evidence that
the transfusion of BM cells might benefit patients suffering the
end-stage liver diseases, including those caused by liver cirrhosis,
hepatitis virus B and hepatitis virus C infections, and alcohol abuse
[3–8]. These studies showed that BM cells could contribute to liver
regeneration after partial hepatectomy (PHx) [3], and reduce liver
fibrosis in mouse disease models [4,5]. Several groups have further
shown the roles of EPC in liver regeneration and in the therapy of
liver cirrhosis [6–8].
Since the discovery of EPC in the circulation of adults, great
efforts have been made to characterize these cells and to show the
roles of EPC in postnatal vasculogenesis and vessel repair [9]. EPC
from BM or peripheral blood (PB) can be cultured and expanded
in vitro [10–12], and bear the stem/progenitor cell markers like
CD133, Sca-1, c-kit, and CD34, and the endothelial markers
including Flk-1, CD31, vWF, UEA-1, and Tie-2 as well [13]. A
large body of evidence has shown that EPC can be mobilized from
BM and can home to wounded tissues [9]. EPC homed to the
injury site can differentiate into endothelial cells (EC) to directly
participate in vasculogenesis, and/or to produce angiogenic
factors to contribute to vascular remodeling. Although these
studies have prompted trials to use EPC to treat ischemic diseases
[9] as well as to facilitate liver regeneration [6–8], signals
regulating EPC mobilization and homing in vivo have been
elusive. Among the molecules identified so far, such as angiogenic
factors [14], integrins [15] and adhesion molecules [16], the
chemokine receptor CXCR4-mediated signaling appears essential
for EPC mobilization, migration, and differentiation [17]. SDF-
1a, the ligand of CXCR4, is important in the trafficking and the
homing of BM-derived cells including EPC [2,18–21]. SDF-1a
induced by hypoxia inducing factor-1a (Hif-1a) enhances the
adhesion, migration, and homing of circulating CXCR4-positive
EPC to ischemic tissues [20,21]. But how SDF-1a-CXCR4
signaling is regulated in the mobilization and the recruitment of
EPC to the injured tissues has been unclear.
Notch signaling represents a type of direct cell-cell communi-
cation that is essential for the regulation of proliferation, apoptosis,
and fate decisions in stem/progenitor cells [22,23]. Recently,
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ronment was required for EPC development [24]. However, how
the Notch signaling pathway exerts its roles in EPC has not been
fully understood. The DNA-binding protein RBP-J (recombina-
tion signal binding protein-JK) mediates signaling from all four
mammalian Notch receptors by associating with the Notch
intracellular domain (NICD), which is released upon the receptor
triggering. This protein-protein interaction transactivates the
genes downstream to RBP-J [22]. Notch signaling plays a pivotal
role in the vascular system [23]. Using a RBP-J conditional knock-
out mouse model, which phenocopies Notch deletion in multiple
tissues, we recently showed that Notch signaling is critical in the
maintenance of vascular homeostasis and EC-related functions
[25,26]. In this study, we report that Notch signaling regulates the
mobilization and homing of EPC, probably by the dynamic
modulation of CXCR4 expression.
Results
Mice transfused with the RBP-J deficient BM cells showed
retarded SEC and hepatocyte regeneration after PHx
To determine the role of the Notch-RBP-J signaling pathway in
EPC, we employed the RBP-J conditional knockout mouse crossed
with the Mx-Cre transgenic mouse, in which injection of poly(I)-
poly(C) could induce almost 100% of RBP-J deletion in BM [27].
Fujii et al have shown that BM cells transfused into mice
participate in liver regeneration after PHx, probably by commit-
ment to SEC through EPC [3]. Therefore, we transfused BM cells
from RBP-J deficient and control mice into normal irradiated
mice. This BM transplantation led to more than 95% of blood
cells of recipient mice derived from the donor BM cells 2 months
later (result not shown). The mice transfused with the RBP-J
deficient BM cells and the control BM cells were subjected to PHx,
and the regeneration of SEC was evaluated on the third day after
PHx, by immunofluorescent staining for Flk-1 and UEA-1. The
result showed that the SEC regeneration was remarkably
attenuated in the mice accepting RBP-J deficient BM cells
compared to the mice accepting the control BM cells (Fig. 1A
top and middle, and B, C). Moreover, we examined the
proliferation of hepatocytes, a major mechanism of PHx-triggered
liver regeneration. Ki67 staining demonstrated that proliferating
hepatocytes (with Ki67
+ round nuclei) were significantly less in
mice transfused with RBP-J deficient BM cells (Fig. 1A bottom and
D). These data suggested that mice with RBP-J-deleted BM cells
were less efficient in liver regeneration than mice with normal BM
cells, probably due to abnormal Notch signaling in EPC.
Attenuated homing of the RBP-J deficient BM EPC into
liver during liver regeneration
We then compared the homing of the RBP-J deficient and the
control EPC into the regenerating liver after PHx. Normal
irradiated mice were subjected to PHx. On the second day of the
operation, these mice were transfused with BM cells that were
isolated from the RBP-J knockout mice or the control mice and
were labeled with Dio. Two more days later (third day after PHx),
mice were perfused, and Dio
+ cells homed into the liver were
examined under fluorescent microscope. As shown in Fig. 2A
(upper) and B, BM cells from RBP-J deficient mice appeared to
home into the regenerating liver less efficiently. We further
performed immunofluorescence to evaluate the homing of RBP-J
Figure 1. Mice transfused with the RBP-J deficient BM cells showed attenuated SEC and hepatocyte regeneration after PHx. BM cells
were isolated from the RBP-J deficient or the control mice, and were transfused into irradiated normal mice. Two months later, the recipient mice
were subjected to PHx, and were analyzed 3 days after the operation. (A) The immunofluorescent staining of UEA-1 (top), Flk-1 (middle), and Ki67
(bottom) with the liver sections of the recipient mice after PHx. (B, C) UEA-1- (B) and Flk-1- (C) positive signals in the upper and middle panels of (A)
were quantified by the representative pixels, and were compared between the two groups. (D) Ki67
+ round nuclei were counted under microscope,
and were compared between the two groups. KO, RBP-J gene knockout mice; Con, control mice. Bars=mean6SD; n=4; ** P,0.01.
doi:10.1371/journal.pone.0007572.g001
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significantly less EPC or their derivatives (UEA-1
+Dio
+) were
detected in the liver of mice accepting RBP-J deficient BM cells
(Fig. 2A, lower, and C). SEC were collected from the regenerating
liver using CD146-magnetic beads, and analyzed by FACS. The
result showed that compared with the control, significantly less
RBP-J deficient EPC or their derivatives (Dio
+Flk-1
+) were homed
into the liver (Fig. 2D). These observations suggested that the
blockade of Notch-RBP-J signaling in BM EPC retarded their
homing to liver during liver regeneration after PHx.
The dynamic change of the CXCR4 expression in the
RBP-J deficient EPC
SDF-1a-CXCR4 signaling has been shown to be the major
signaling involved in the EPC mobilization. Injured tissue cells
secret SDF-1a, the specific ligand for CXCR4, to chemotactically
mobilize EPC from BM [2,28]. We investigated the CXCR4
expression on EPC in BM and the peripheral blood of the RBP-J
deficient and the control mice. The result showed that in BM, the
CXCR4 expression on EPC was significantly decreased after
RBP-J disruption (Fig. 3A and C). In contrast, the inactivation of
RBP-J up-regulated the CXCR4 expression on EPC in PB (Fig. 3B
and D). We examined the number of EPC in BM and PB of RBP-J
knockout mice. As shown in Fig. 3E and Fig. 3F, the disruption of
RBP-J led to the significant decrease of CD133
+Flk-1
+ EPC in
BM, with a concomitant increase of EPC in PB. These results
implied that more EPC were mobilized into the circulation.
Therefore, the blockade of Notch-RBP-J signaling might result in
autonomous mobilization of EPC from BM into PB, likely through
the interference of CXCR4 expression. However, when we
transplanted BM cells from the RBP-J deficient and the control
mice into irradiated wild type mice, we did not observe significant
difference in PB EPC or CXCR4 level between the RBP-J
deficient group and the control group, suggesting that the
mobilization of EPC into PB needs other signals.
Inactivation of RBP-J increased EPC mobilization induced
by PHx
We then examined the PHx-induced EPC mobilization in the
absence of the Notch-RBP-J signaling. The RBP-J knockout and
the control mice were subjected to PHx, and EPC in PB were
evaluated by FACS and cell counting. On day 1, 3 and 10
following PHx, more EPC were detected in PB of the RBP-J
knockout mice as compared with the controls (Fig. 4A). The
expression of CXCR4 on EPC was also up-regulated on these days
after the PHx operation (Fig. 4B). The day 6 was special in that no
significant difference in EPC level was detected between the RBP-J
knockout and the control mice, while the expression of CXCR4 on
the RBP-J knockout EPC was lower than that of the control EPC.
These results suggested that the EPC mobilization was enhanced,
correlating with the disturbed CXCR4 expression on EPC in the
absence of RBP-J.
RBP-J ablation damaged the functions of BM-derived EPC
in vitro
Several properties, including adhesion and migration, are
closely related to the functions of EPC in vasculogenesis [9,24].
We then cultured BM EPC under the condition described in vitro
[29]. We compared the CXCR4 expression on the cultured EPC,
Figure 2. Lowered recruitment of the RBP-J-deleted EPC into the regenerating liver after PHx. Normal mice were subjected to PHx. On
the next day of the operation, mice were irradiated, and were transfused with Dio-labeled BM cells from the RBP-J deficient (KO-BMT) or the control
(Con-BMT) mice. The recipient mice were analyzed 2 days after the BM transplantation (3 days after PHx). (A) The livers of the recipient mice suffering
PHx were sectioned, stained for UEA-1, and were examined for Dio
+ cells (upper) and UEA-1
+Dio
+ cells (lower). (B, C) Dio
+ cells and UEA-1
+Dio
+ cells
in (A) were quantitatively represented by corresponding pixels (bars=mean6SD; n=4; ** P,0.01; *** P,0.001). (D) Livers were perfused with PBS.
SECs were purified from the livers of the recipient mice using a kit, and were analyzed for Flk-1
+Dio
+ cells. The cytograph represented 4 independent
experiments with the same results.
doi:10.1371/journal.pone.0007572.g002
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deletion of RBP-J (Fig. 5A). We then assessed EPC migration using
a transwell assay. The result showed that RBP-J deficient EPC had
a remarkably reduced migration capacity in response to SDF-1a
(Fig. 5B and C). Therefore, RBP-J-disrupted EPC had lowered
ability to migrate, probably due to their lowered CXCR4
expression. Moreover, the culture of RBP-J deficient BM
generated decreased number of EPC (Fig. 5D and E) when
compared with the control cultures, consistent with Kwon’s results
[24]. Cells attached to the gelatin-coated dishes on day 3 of the
culture were counted, and the result showed that the adhesion
ability of EPC was impaired in the absence of RBP-J (Fig. 5F).
Impaired vessel formation in the RBP-J-deleted EPC was
rescued by the over-expression of CXCR4
EPC homed to the injury site can differentiate into EC to
directly participate in vasculogenesis [9]. We compared the vessel
formation ability between the RBP-J deficient and the control
EPC. When cultured in Matrigel, EPC could form vessel-like
structures (Fig. 6A). We found that the RBP-J knockout EPC could
seldom form vessel-like structures when cultured in Matrigel
(Fig. 6A and B). Similar defects in vessel formation were also
detected when the RBP-J deficient EPC were cultured in ECM
(Fig. 6D). Because the RBP-J deficient BM EPC had lowered
CXCR4 expression, we transfected RBP-J knockout EPC with a
Lentivirus expressing the mouse CXCR4 (Fig. 6C), and performed
the vessel formation assay in ECM. The result showed that the
over-expression of CXCR4 in EPC could partially rescue the
defects in vessel formation of RBP-J deficient EPC (Fig. 6D and E).
These results indicated that the Notch-RBP-J signaling was
essential for the vessel formation by EPC, probably through
CXCR4 expression.
Discussion
The BM-derived EPC transplantation has been used in
experimental therapy to facilitate liver regeneration. Transfused
EPC can home to injured livers, and directly differentiate into
SEC and integrated into liver sinusoids. They can also indirectly
facilitate SEC and hepatocyte regeneration by paracrine mecha-
nisms [30–32]. Our results suggested that the Notch signaling
might play a role for the transfused BM-derived EPC to facilitate
liver regeneration. When Notch signaling was interrupted, the
BM-derived EPC appeared to have lower CXCR4 expression
(Fig. 5A). Notch signaling is essential for these BM-derived EPC to
incorporate into liver tissues and/or to participate in liver
regeneration. Our results showed that the Notch signaling-
mediated CXCR4 expression is necessary for EPC to participate
in vessel formation. Furthermore, we have previously shown that
RBP-J deficient SEC have attenuated capacity in supporting
hepatocyte regeneration due to the lowered level of VEGFR1
expression [26]. These results suggested that the modification of
Figure 3. Disruption of RBP-J modulated the CXCR4 expression
and the mobilization of EPC. Mice with different genotypes were
induced to disrupt RBP-J, and BM and the peripheral blood (PB) cells
were analyzed by FACS. (A, B) The expression of CXCR4 on CD133
+Flk-
1
+ EPCs in BM (A) and PB (B) of the RBP-J deficient and the control mice
was analyzed by FACS. (C, D) FACS analyses shown in (A) and (B) were
repeated, and MFI of the CXCR4 expression was analyzed statistically
(bars=mean6SD; n=5; * P,0.05). (E, F) The number of CD133
+Flk-1
+
EPCs in BM (E) and PB (F) of the RBP-J deficient and the control mice
was determined by cell counting and FACS analysis (bars=mean6SD;
n=5;*P,0.05; ** P,0.01).
doi:10.1371/journal.pone.0007572.g003
Figure 4. EPC mobilization in the RBP-J mutant and the control
mice following PHx. The RBP-J deficient and the control mice were
subjected to PHx. The number of EPC in PB (A) and the CXCR4
expression (B) on EPC in PB were analyzed by cell counting and FACS
analysis at different time points (bars=mean6SD; n=5; * P,0.05;
** P,0.01; NS, no statistical significance).
doi:10.1371/journal.pone.0007572.g004
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enhance the function of EPC in the therapy of liver diseases.
Although EPC have been shown to participate in liver
regeneration [3] and might have therapeutic potentials in the
treatment of end-stage liver diseases [6–8], how these cells are
regulated in vivo has been poorly understood. The Notch-RBP-J
signaling pathway is involved in the regulation of multiple lineages
of stem/progenitor cells. In this study, using an inducible RBP-J
knockout mouse model, we showed that Notch signaling might
influence EPC at different levels or stages. In BM, the deficiency of
the canonical Notch signaling led to the reduction of EPC, but a
substantial fraction of EPC exists, suggesting that the Notch-RBP-J
pathway is not essential for EPC commitment. Kwon et al
reported a similar phenotype in the Notch ligand Jagged-1
knockout mice [24]. In the RBP-J deficient mice, however, we
observed a concomitant increase of EPC in the peripheral blood.
Because the RBP-J deficient EPC in BM showed lowered CXCR4
expression, we propose that the canonical Notch signaling
represses EPC mobilization in BM by the maintenance of CXCR4
expression. In PB, RBP-J deficient EPC have up-regulated
CXCR4, implying that Notch signaling might repress CXCR4
expression and EPC recruitment to injured tissues, since literature
has indicated that the CXCR4 expression is closely related to the
EPC recruitment into injured tissues, which produce SDF-1a
[20,21]. However, in the RBP-J knock-out model, although EPC
in PB showed higher CXCR4 expression (Fig. 3 and 4), they were
recruited into the regenerating liver (which produces SDF-1a)a ta
lower efficiency (Fig. 2). This suggests that additional Notch-
regulated signals are also necessary for the homing of EPC from
PB into the injured tissues, and further molecular studies are
needed to identify these signals.
Materials and Methods
Ethnics Statements
The animal husbandry, experiments and welfare were conduct-
ed in accordance with the Detailed Rules for the Administration of
Animal Experiments for Medical Research Purposes issued by the
Ministry of Health of China, and were approved by the Animal
Experiment Administration Committee of Fourth Military Med-
ical University. Mice were raised in the specific pathogen free
(SPF) conditions on the C57BL/6 background, and were
manipulated with every specific care to reduce the suffering of
the mice during the experiments.
Mice
The RBP-J-floxed mice and the Mx-Cre transgenic mice were
as described [27]. The RBP-J-floxed mice were crossed with the
Mx-Cre mice to obtain heterozygous and homozygous mice
bearing the Mx-Cre transgene (RBP
+/f-MxCre and RBP
f/f-
MxCre, as the control and the RBP-J knockout mice, respectively),
as genotyped by PCR [27]. The Cre-mediated deletion of RBP-J
was induced by the intra-peritoneal injection of poly(I)-poly(C)
(Sigma, St. Louis, MI) into 6-week-old mice with demanded
genotypes, with a schedule descried in [27]. One week after the
last injection, the mice were subjected to further analysis. PHx was
performed as described [26].
BM transplantation
The femurs and tibias of mice were dissected and flushed with
phosphate-buffered saline (PBS). BM cells were resuspended at a
density of 1610
7/ml. Wild type congenic mice as recipients were
irradiated with 8 Gy c-ray one day before the transfusion with
Figure 5. Effect of the RBP-J deletion on the in vitro cultured EPC. (A) The expression of CXCR4 on the cultured EPC was accessed by FACS
analysis. (B, C) In vitro migration assay. Transwell culture was set up, with EPC from the RBP-J-deleted and the control mice in the upper chamber,
and SDF-1a in the lower chamber. A photograph of EPC in the lower chamber (B) was taken, and cells in the lower chamber (C) were counted 18 h
after the starting of the culture (bars=mean6SD; n=4; ** P,0.01). (D) The formation of colonies by the cultured RBP-J knockout and the control
EPC. (E) The number of total EPC formed 7 days after the culture. (F) The number of EPC attached on the gelatin-coated dishes 3 days after the
culture. (bars=mean6SD; n=4; * P,0.05).
doi:10.1371/journal.pone.0007572.g005
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6 BM cells via tail vein. In some experiments, cells were
stained with Dio (Invitrogen, Carlsbad, CA) for 15 min, and were
transfused into recipients. The mice were kept with water
containing antibiotics (1.1 g/L of neomycin sulphate) until further
analyses.
Immunofluorescence
Liver embedded in OCT was sectioned at 10 mm thickness. For
the staining, sections were fixed with 4% paraformaldehyde and
were stained with FITC-conjugated anti-Flk-1 (Chemicon Inter-
national), Rhodamine-UEA-l (Vector Laboratories, Burlingame,
CA), or Cy3-conjugated anti-Ki67 (Santa Cruz Biotechnology,
Santa Cruz, CA). Images were taken using a fluorescence
microscope (Olympus BX51, Japan) with a CCD camera, or a
confocal microscope (FV1000, Olympus).
Flow cytometry
Single cell suspensions were prepared from cultured cells or
freshly collected from PB, BM, or liver of mice. Following the
treatment with buffered 0.14 M NH4Cl, cells (325610
5) were
stained with antibodies for 30 min on ice, and were analyzed using
a FACSCalibur
TM (BD Immunocytometry Systems, San Jose,
CA). Data were analyzed using the CellQuest
TM software. Dead
cells were excluded by propidium iodide (PI) staining. Anti-mouse-
CD133-FITC, biotinylated anti-mouse-Flk-1, biotinylated anti-
mouse-CD184 (CXCR4, 2B11) and streptavidin-APC were
purchased from BD PharMingen (San Diego, CA).
Isolation and culture of EPC
EPC were cultured as described previously [29]. Briefly, BM
mononuclear cells were collected and cultured in 2% gelatin-
coated 6 well dishes, using the Dulbecco’s modified Eagle’s
medium (DMEM) containing 20% fetal calf serum (FCS), 50 mg/
ml endothelial cell growth supplement (ECGS, Sigma), heparin
(100 mg/ml) and antibiotics. Attached cells were allowed to
develop into EPC for 7 days in the culture. EPC adhered to
gelatin was evaluated by counting the attached cells on day 3 after
the replacement of the medium. EPC were then analyzed by
FACS or observed under a microscope on day 7.
Migration assay
Chemotaxis experiments were performed in polycarbonate
transwell inserts (5-mm pore, Corning Costar Corp.). SDF-1a
(Peprotech) was added in the lower chamber at the concentration
of 100 ng/ml. The cultured EPC (1610
5) were seeded in the
upper compartment and were cultured at 37uC for 18 h. Migrated
cells in the lower chamber were photographed and counted under
a microscope.
Vessel formation assay
Matrigel (BD Bioscience) or extracellular matrix (ECM, Sigma,
St. Louis, MI) was added to 24-well plates in the volume of 300 ml
and was allowed to solidify at 37 uC for 30 min. The equal volume
of medium was added and was incubated for another 30 min. BM
EPC (2610
6) were then seeded and were cultured with required
Figure 6. Over-expression of CXCR4 rescued the defects in vessel formation of the RBP-J deficient EPC. (A) Vessel formation by the
cultured EPC with different genotypes in matrigel. (B) The quantitative analysis of vessel length in (A) (bars=mean6SD; n=4; ** P,0.01). (C) The
overexpression of the mouse CXCR4 by Lentivirus infection. HeLa cells were infected with different virons and the CXCR4 expression was assessed by
FACS. (D) EPC with different genotypes were transduced with the Lentivirus vector or the Lentivirus expressing CXCR4, and were assayed for the
vessel formation capability in the ECM culture system. (E) The quantification of the vessel length in (D) (bars=mean6SD; n=4; * P,0.05;
*** P,0.001).
doi:10.1371/journal.pone.0007572.g006
EPC Regulated by Notch
PLoS ONE | www.plosone.org 6 October 2009 | Volume 4 | Issue 10 | e7572supplements. After 7 to 10 days, the tube-shaped vessels in the
Matirgel or ECM were photographed under a microscope.
Lentivirus infection
The coding region of the mouse CXCR4 cDNA fragment was
fused with the IRES-EGFP unit, and was inserted into pLenti-
EGFP (kindly provided by Dr Xiao-Bing Wu) to replace the EGFP
gene, to generate pLenti-CXCR4. pLenti-EGFP and pLenti-
CXCR4 were transfected into the 293FT cells using Lipofecta-
mine 2000, together with the packaging plasmids (Invitrogen),
according to the manufacturer’s protocols. The supernatants were
collected 48 h after the transfection, and the virons were
concentrated by ultracentrifugation at 70,000 g, at 4 uC for 2 h.
The pellets were resuspended in DMEM and stored at 280 uC.
For infection, EPC were co-cultured with the viral suspensions for
48 h, and were then cultured in normal medium until further
analysis.
Statistics
Images were imported into the Image Pro Plus 5.1 software, and
the pixels for each color were analyzed to quantitatively represent
the positively stained cells. Statistical analysis was performed with
the SPSS 12.0 program. Results were expressed as means 6 SD.
Comparisons between groups were undertaken using unpaired
Student’s t-test. P,0.05 was considered statistically significant.
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